News

Phase III study of RPE65 for Leber’s congenital amaurosis under way, among other research

SLO-MP shows higher structure/function correlation compared with standard perimetry

Management requires aggressive therapy of inflammation, medical therapy of elevated IOP

Phase III study of RPE65 for Leber’s congenital amaurosis under way, among other research

Man has 3-day history of OD pain, decreased vision, other symptoms: What is diagnosis?

Why unintended consequences can have bad results

Why an effective campaign must be readily available for physicians to implement

Avoiding hypotropia, excyclotropia after augmented transposition surgery among tips

The journey to achieving the perfect lens calculation is now just a few years away from reaching its destination.

A team of scientists reports that it has found a way to isolate retinal pigment epithelium cells from human pluripotent stem cells as early as 14 days following the onset of differentiation.

The Tecnis toric 1-piece IOL (Abbott) has received FDA approval, and the company is launching the lens in the United States for treatment of cataract patients with pre-existing corneal astigmatism.

Three keynote speakers, including two Nobel laureates, will present lectures during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) May 5 to 9 at the Washington State Convention Center. This year, the ARVO/Alcon Keynote Series will include Oliver Smithies, DPhil, Roger Tsien, PhD, and Christopher Murray, MD, DPhil.

With a change of venue and scenery, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) hits the road this year, moving from its long-time home in Fort Lauderdale, FL, to Seattle. With a central theme of “Life-changing research,” the 2013 conference will focus on how vision researchers make a difference.

Attendees of the 2013 meeting of the Association for Research in Vision and Ophthalmology (ARVO) will want to make time for three special sessions at the Washington State Convention Center. These sessions include results from the Age-Related Eye Disease Study 2 (AREDS2), Inhibition of VEGF in Age-related Choroidal Neovascularisation 2 (IVAN2) Study, and Groupe d’Evaluation Français Avastin versus Lucentis (GEFAL) Study, as well as the National Eye Institute audacious goals initiative.

Corneal crosslinking using the current technique is safe and effective for stabilizing eyes with progressive corneal ectasia, but new treatment protocols and new indications are emerging.

Cartridges pre-loaded by an eye bank (EndoGlide, Angiotech Pharmaceuticals Inc.) have been successfully used in corneal transplantation.

Edward Peterson, president and chief executive officer of AcuFocus Inc., will resign from the company effective April 30, 2013.

Leica Microsystems and Bausch + Lomb have announced that Bausch + Lomb will distribute Leica ophthalmic surgical microscopes and accessories in select markets.

Ophthalmic Women Leaders (OWL) honored the recipients of three awards at its annual Monday night reception during the 2013 meeting of the American Society of Cataract and Refractive Surgery.

What is the most effective procedure to remove corneal epithelium? A single metallic blade or hockey-stick knife has been used since the 1980s. Excimer lasers have been used since the 1990s. The initial report on the first 25 patients treated with a new, double-blade device was presented by Matsliah Taieb, MD.

An ocular bandage that has been on the market in Europe for several years is receiving praise from clinicians familiar with the product. Matteo Piovella, MD, has been using the bandage on every eye he has operated on for the past 4 years.

Two-year data on a subconjunctival implant suggest that the device is both safe and effective in lowering IOP in both refractory glaucoma and early stages of the disease. Results from the multicenter, international study were presented by Steven Vold, MD.

Much has been written about the high-tech phenomenon in today's fast-paced world. Just "Google" it on your WiFi-supported tablet or device here at the American Society of Cataract and Refractive Surgery meeting and check out the latest statistics on how these devices are permeating our lives.

Limbal relaxing incisions have been recognized as an effective tool in reducing corneal astigmatism at least since the 1990s. Surgeons have also recognized that preoperative measurements and surgical plans do not always provide the best possible results, said Kerry Assil, MD.

Although cataract surgery is already the most-used intervention for glaucoma, a growing number of glaucoma specialists want to see timely glaucoma surgery accepted and reimbursed as an appropriate intervention for the long-term management of glaucoma, said Kuldev Singh, MD, MPH, professor and chief of the Glaucoma Service at Stanford University, Stanford, CA.

A new generation of drug delivery devices promises to make eye drops the drug delivery vehicle of the past, according to Ike K. Ahmed, MD, assistant professor at the University of Toronto.

With all the new technology and ideas that will surface here in San Francisco over the next 4 days, Ophthalmology Times has a front row seat to the stage of innovation.

Much of the guesswork about how to manage dry eye disease was clarified by the results of the Dry Eye Workshop, which established a practical, easy-to-use assessment tool and stepwise treatment approach, said Deepinder Dhaliwal, MD, associate professor of ophthalmology and director, Cornea and Refractive Surgery at the University of Pittsburgh Medical Center.